Ascidian Therapeutics’ Post

View organization page for Ascidian Therapeutics, graphic

6,261 followers

“A first big pharma partnership for Ascidian, headed up by ex-Biogen research head Michael Ehlers, as [Roche] expands its gene editing and neuroscience efforts.” Thanks, Andrew McConaghie and Citeline/Scrip for sharing the news and explaining why we believe #RNA #ExonEditing could “create therapies for conditions not amenable to existing gene therapy and gene-editing technologies.” 👉 https://lnkd.in/evcDNtff  

To view or add a comment, sign in

Explore topics